Menu

Pasithea Therapeutics Corp. KTTA

Full chart Compare
Set alert

Price alert · KTTA

All alert types
0.53 USD -0.04 (-7.28%)

At closeNov 12, 2026, 7:41 AM EST

0.57 +0.03 +6.39%

Pre-market · Nov 12, 7:41 AM ET

0.5251 Day range 0.5695
0.281 52-week range 2.06
YTD
-58.76%
1 year
-24.32%

Revenue & Expenses

Other Income → Expenses: $2.33MExpenses → Gross Loss: $2.21KExpenses → Selling, General & Admin: $4.51MExpenses → Interest Expense: $508Net Loss → Expenses: $2.17MRevenue → Cost of Revenue: $15.06KOther Income$2.33MNet Loss$2.17MCost of Revenue$17.27KExpenses$4.51MGross Loss$2.21KSelling, General & Admin$4.51MInterest Expense$508Revenue$15.06K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

KTTA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
20.86M14.25M15.98M12.59M4.51M
7.98M7.20M8.10M2.67M0
12.88M7.05M7.88M9.92M4.51M
-20.86M-14.25M-15.98M-12.59M-4.51M
-20.43M-13.90M-15.96M-13.94M-2.17M
-20.43M-13.90M-15.96M-13.94M-2.17M
-20.43M-13.90M-15.96M-13.94M-2.17M
-20.43M-13.90M-15.96M-13.94M-2.17M
-2.91-12.69-13.01-11.03-4.20
-2.91-12.69-13.01-11.03-4.20
-2.91-12.69-13.01-11.03-4.20
-20.43M-13.90M-15.96M-13.94M-2.17M
-20.43M-13.90M-15.96M-13.94M-2.17M
7.03M1.10M1.23M1.26M520.23K
7.03M1.10M1.23M1.26M520.23K